Category: Press Release - Page 2 - Psychedelic Alpha

Read more about the article PharmaTher Announces FDA Acceptance, As a Priority Original Abbreviated New Drug Application, for KETARX™ (Ketamine)

PharmaTher Announces FDA Acceptance, As a Priority Original Abbreviated New Drug Application, for KETARX™ (Ketamine)

Post published:September 27, 2023
Post category:Press Release

Read more about the article Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder

Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder

Post published:September 26, 2023
Post category:Press Release

Read more about the article Numinus Wellness Inc. Announces At-The-Market Offering Equity Program

Numinus Wellness Inc. Announces At-The-Market Offering Equity Program

Post published:September 26, 2023
Post category:Press Release

Read more about the article Gilgamesh Pharmaceuticals Successfully Completes Phase 1 SAD/MAD Clinical Trials of GM-1020

Gilgamesh Pharmaceuticals Successfully Completes Phase 1 SAD/MAD Clinical Trials of GM-1020

Post published:September 21, 2023
Post category:Press Release

Read more about the article Transcend Therapeutics and Yale awarded U.S. Department of Defense grant to study methylone for PTSD

Transcend Therapeutics and Yale awarded U.S. Department of Defense grant to study methylone for PTSD

Post published:September 21, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH AND JAGUAR HEALTH JOINT VENTURE MAGDALENA BIOSCIENCES COMPLETES IMPORT OF COCA LEAF FROM PERU

FILAMENT HEALTH AND JAGUAR HEALTH JOINT VENTURE MAGDALENA BIOSCIENCES COMPLETES IMPORT OF COCA LEAF FROM PERU

Post published:September 21, 2023
Post category:Press Release

Read more about the article Silo Pharma Announces Positive Data on SPC-15 for PTSD and Prepares to File Pre-Investigational New Drug (IND) Application with FDA

Silo Pharma Announces Positive Data on SPC-15 for PTSD and Prepares to File Pre-Investigational New Drug (IND) Application with FDA

Post published:September 20, 2023
Post category:Press Release

Read more about the article Numinus Congratulates MAPS on its Phase 3 Study Results Published in Nature Medicine

Numinus Congratulates MAPS on its Phase 3 Study Results Published in Nature Medicine

Post published:September 19, 2023
Post category:Press Release

Read more about the article Numinus Takes Actions to Accelerate its Path to Profitability by Focusing on Positive Cash Flow Generating Operations

Numinus Takes Actions to Accelerate its Path to Profitability by Focusing on Positive Cash Flow Generating Operations

Post published:September 19, 2023
Post category:Press Release

Read more about the article COMPASS Pathways appoints Daphne Karydas to its Board of Directors

COMPASS Pathways appoints Daphne Karydas to its Board of Directors

Post published:September 19, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.